Switch to:
Also traded in: Germany, Hongkong

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.76
SHTDF's Cash-to-Debt is ranked lower than
51% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.74 vs. SHTDF: 0.76 )
Ranked among companies with meaningful Cash-to-Debt only.
SHTDF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.39  Med: 0.95 Max: 148.47
Current: 0.76
0.39
148.47
Equity-to-Asset 0.20
SHTDF's Equity-to-Asset is ranked lower than
84% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. SHTDF: 0.20 )
Ranked among companies with meaningful Equity-to-Asset only.
SHTDF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.12  Med: 0.21 Max: 0.36
Current: 0.2
0.12
0.36
Interest Coverage 5.01
SHTDF's Interest Coverage is ranked lower than
76% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.37 vs. SHTDF: 5.01 )
Ranked among companies with meaningful Interest Coverage only.
SHTDF' s Interest Coverage Range Over the Past 10 Years
Min: 3.43  Med: 4.42 Max: 7.37
Current: 5.01
3.43
7.37
Piotroski F-Score: 7
Altman Z-Score: 2.63
Beneish M-Score: -2.60
WACC vs ROIC
7.64%
14.97%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 3.96
SHTDF's Operating Margin % is ranked higher than
53% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.78 vs. SHTDF: 3.96 )
Ranked among companies with meaningful Operating Margin % only.
SHTDF' s Operating Margin % Range Over the Past 10 Years
Min: 2.54  Med: 3.58 Max: 4.04
Current: 3.96
2.54
4.04
Net Margin % 1.80
SHTDF's Net Margin % is ranked lower than
51% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.65 vs. SHTDF: 1.80 )
Ranked among companies with meaningful Net Margin % only.
SHTDF' s Net Margin % Range Over the Past 10 Years
Min: 1.35  Med: 1.54 Max: 1.84
Current: 1.8
1.35
1.84
ROE % 14.74
SHTDF's ROE % is ranked higher than
76% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.33 vs. SHTDF: 14.74 )
Ranked among companies with meaningful ROE % only.
SHTDF' s ROE % Range Over the Past 10 Years
Min: 10.4  Med: 12.1 Max: 30.58
Current: 14.74
10.4
30.58
ROA % 3.06
SHTDF's ROA % is ranked lower than
60% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.93 vs. SHTDF: 3.06 )
Ranked among companies with meaningful ROA % only.
SHTDF' s ROA % Range Over the Past 10 Years
Min: 2.44  Med: 2.9 Max: 3.98
Current: 3.06
2.44
3.98
ROC (Joel Greenblatt) % 27.94
SHTDF's ROC (Joel Greenblatt) % is ranked higher than
60% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.27 vs. SHTDF: 27.94 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SHTDF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 20.23  Med: 33.77 Max: 113.07
Current: 27.94
20.23
113.07
3-Year Revenue Growth Rate 7.40
SHTDF's 3-Year Revenue Growth Rate is ranked higher than
64% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.40 vs. SHTDF: 7.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SHTDF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.4  Med: 24.25 Max: 33.2
Current: 7.4
7.4
33.2
3-Year EBITDA Growth Rate 11.10
SHTDF's 3-Year EBITDA Growth Rate is ranked higher than
54% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.40 vs. SHTDF: 11.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SHTDF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 11.1  Med: 28.6 Max: 61.5
Current: 11.1
11.1
61.5
3-Year EPS without NRI Growth Rate 18.40
SHTDF's 3-Year EPS without NRI Growth Rate is ranked higher than
58% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.30 vs. SHTDF: 18.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SHTDF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 17  Med: 21.1 Max: 116.1
Current: 18.4
17
116.1
GuruFocus has detected 2 Warning Signs with Sinopharm Group Co Ltd $SHTDF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SHTDF's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with SHTDF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 325412 
Compare:NAS:HSIC, OTCPK:SHPMY, NYSE:ABC, NAS:PDCO, NYSE:PBH, NYSE:OMI, NYSE:PMC, NYSE:CAH, OTCPK:SNYR, OTCPK:FZMD, OTCPK:SCVM, NYSE:MCK » details
Traded in other countries:X2S.Germany, 01099.Hongkong,
Headquarter Location:China
Sinopharm Group Co Ltd is a pharmaceutical distributor. The Company distributes pharmaceutical products to hospitals and clinics and operates pharmaceutical chain stores. Its segments are Pharmaceuticals distribution, Retail pharmacy, and Other business.

Sinopharm Group Co Ltd was incorporated in the People's Republic of China on January 8, 2003. The Company along with its subsidiaries is engaged in distribution of medicines, medical device and pharmaceutical products to hospitals, other distributors, retail drug stores and clinics, operation of pharmaceutical chain stores, and distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products. The Company's operations are divided into three segments Pharmaceuticals distribution segment, Retail pharmacy segment and Other business segment. Pharmaceutical distribution is the Group's principal business. The Company provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, customers and other suppliers. The Company has manages a network of retail drug stores in cities of China via direct operations and franchises. The Company is also engaged in the production and sale of pharmaceutical products, chemical reagents and laboratory supplies, and also engaged in the innovation of pharmaceutical, medical services and other health-related industries, to explore the synergistic development of its diversified businesses.

Ratios

vs
industry
vs
history
PE Ratio 17.94
SHTDF's PE Ratio is ranked higher than
62% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.66 vs. SHTDF: 17.94 )
Ranked among companies with meaningful PE Ratio only.
SHTDF' s PE Ratio Range Over the Past 10 Years
Min: 15.94  Med: 23.54 Max: 60.57
Current: 17.94
15.94
60.57
PE Ratio without NRI 17.94
SHTDF's PE Ratio without NRI is ranked higher than
64% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.98 vs. SHTDF: 17.94 )
Ranked among companies with meaningful PE Ratio without NRI only.
SHTDF' s PE Ratio without NRI Range Over the Past 10 Years
Min: 15.94  Med: 23.54 Max: 60.57
Current: 17.94
15.94
60.57
Price-to-Owner-Earnings 16.98
SHTDF's Price-to-Owner-Earnings is ranked higher than
86% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.77 vs. SHTDF: 16.98 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SHTDF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.63  Med: 32.56 Max: 261.61
Current: 16.98
6.63
261.61
PB Ratio 2.70
SHTDF's PB Ratio is ranked lower than
56% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.47 vs. SHTDF: 2.70 )
Ranked among companies with meaningful PB Ratio only.
SHTDF' s PB Ratio Range Over the Past 10 Years
Min: 1.85  Med: 2.72 Max: 6.13
Current: 2.7
1.85
6.13
PS Ratio 0.33
SHTDF's PS Ratio is ranked higher than
71% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. SHTDF: 0.33 )
Ranked among companies with meaningful PS Ratio only.
SHTDF' s PS Ratio Range Over the Past 10 Years
Min: 0.24  Med: 0.35 Max: 1.1
Current: 0.33
0.24
1.1
Price-to-Free-Cash-Flow 10.85
SHTDF's Price-to-Free-Cash-Flow is ranked higher than
91% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.56 vs. SHTDF: 10.85 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SHTDF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.93  Med: 15.74 Max: 112.15
Current: 10.85
4.93
112.15
Price-to-Operating-Cash-Flow 9.28
SHTDF's Price-to-Operating-Cash-Flow is ranked higher than
91% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.03 vs. SHTDF: 9.28 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SHTDF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.47  Med: 11.97 Max: 51.92
Current: 9.28
4.47
51.92
EV-to-EBIT 9.22
SHTDF's EV-to-EBIT is ranked higher than
83% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.81 vs. SHTDF: 9.22 )
Ranked among companies with meaningful EV-to-EBIT only.
SHTDF' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.3  Med: 11.3 Max: 24.3
Current: 9.22
8.3
24.3
EV-to-EBITDA 9.22
SHTDF's EV-to-EBITDA is ranked higher than
60% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.78 vs. SHTDF: 9.22 )
Ranked among companies with meaningful EV-to-EBITDA only.
SHTDF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.5  Med: 10.2 Max: 21.8
Current: 9.22
7.5
21.8
PEG Ratio 1.20
SHTDF's PEG Ratio is ranked higher than
85% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.00 vs. SHTDF: 1.20 )
Ranked among companies with meaningful PEG Ratio only.
SHTDF' s PEG Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.78 Max: 1.3
Current: 1.2
0.52
1.3
Shiller PE Ratio 33.84
SHTDF's Shiller PE Ratio is ranked lower than
99.99% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 30.82 vs. SHTDF: 33.84 )
Ranked among companies with meaningful Shiller PE Ratio only.
SHTDF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 30.53  Med: 34.37 Max: 36.65
Current: 33.84
30.53
36.65
Current Ratio 1.33
SHTDF's Current Ratio is ranked lower than
69% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.62 vs. SHTDF: 1.33 )
Ranked among companies with meaningful Current Ratio only.
SHTDF' s Current Ratio Range Over the Past 10 Years
Min: 1.09  Med: 1.28 Max: 1.67
Current: 1.33
1.09
1.67
Quick Ratio 1.07
SHTDF's Quick Ratio is ranked higher than
53% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. SHTDF: 1.07 )
Ranked among companies with meaningful Quick Ratio only.
SHTDF' s Quick Ratio Range Over the Past 10 Years
Min: 0.85  Med: 1.04 Max: 1.37
Current: 1.07
0.85
1.37
Days Inventory 36.80
SHTDF's Days Inventory is ranked higher than
55% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.10 vs. SHTDF: 36.80 )
Ranked among companies with meaningful Days Inventory only.
SHTDF' s Days Inventory Range Over the Past 10 Years
Min: 29.09  Med: 36.85 Max: 38.5
Current: 36.8
29.09
38.5
Days Sales Outstanding 83.54
SHTDF's Days Sales Outstanding is ranked lower than
74% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.92 vs. SHTDF: 83.54 )
Ranked among companies with meaningful Days Sales Outstanding only.
SHTDF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 75.63  Med: 94.38 Max: 112.77
Current: 83.54
75.63
112.77
Days Payable 100.02
SHTDF's Days Payable is ranked higher than
67% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 65.77 vs. SHTDF: 100.02 )
Ranked among companies with meaningful Days Payable only.
SHTDF' s Days Payable Range Over the Past 10 Years
Min: 77.07  Med: 103.6 Max: 114.17
Current: 100.02
77.07
114.17

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.42
SHTDF's Dividend Yield % is ranked lower than
69% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.91 vs. SHTDF: 1.42 )
Ranked among companies with meaningful Dividend Yield % only.
SHTDF' s Dividend Yield % Range Over the Past 10 Years
Min: 0.04  Med: 1.06 Max: 1.59
Current: 1.42
0.04
1.59
Dividend Payout Ratio 0.24
SHTDF's Dividend Payout Ratio is ranked higher than
62% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.32 vs. SHTDF: 0.24 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SHTDF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.02  Med: 0.24 Max: 0.28
Current: 0.24
0.02
0.28
3-Year Dividend Growth Rate 13.20
SHTDF's 3-Year Dividend Growth Rate is ranked higher than
76% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. SHTDF: 13.20 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SHTDF' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 6.6 Max: 201.1
Current: 13.2
0
201.1
Forward Dividend Yield % 1.42
SHTDF's Forward Dividend Yield % is ranked lower than
59% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.91 vs. SHTDF: 1.42 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.22
SHTDF's 5-Year Yield-on-Cost % is ranked higher than
97% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.58 vs. SHTDF: 3.22 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SHTDF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.09  Med: 2.4 Max: 3.61
Current: 3.22
0.09
3.61
3-Year Average Share Buyback Ratio -2.50
SHTDF's 3-Year Average Share Buyback Ratio is ranked lower than
57% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.40 vs. SHTDF: -2.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SHTDF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.6  Med: -4.8 Max: -2
Current: -2.5
-13.6
-2

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 12.43
SHTDF's Price-to-Net-Current-Asset-Value is ranked lower than
78% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. SHTDF: 12.43 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
SHTDF' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.59  Med: 8.45 Max: 13.7
Current: 12.43
6.59
13.7
Price-to-Tangible-Book 3.37
SHTDF's Price-to-Tangible-Book is ranked lower than
64% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.78 vs. SHTDF: 3.37 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SHTDF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3  Med: 3.36 Max: 5.55
Current: 3.37
3
5.55
Price-to-Intrinsic-Value-Projected-FCF 0.83
SHTDF's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
99.99% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. SHTDF: 0.83 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SHTDF' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.76  Med: 1.28 Max: 2.43
Current: 0.83
0.76
2.43
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.63
SHTDF's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
99.99% of the 9 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.39 vs. SHTDF: 0.63 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.95
SHTDF's Price-to-Median-PS-Value is ranked lower than
99.99% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. SHTDF: 0.95 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SHTDF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.75  Med: 0.94 Max: 2.38
Current: 0.95
0.75
2.38
Price-to-Peter-Lynch-Fair-Value 1.20
SHTDF's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.01 vs. SHTDF: 1.20 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SHTDF' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.78  Med: 0.92 Max: 1.74
Current: 1.2
0.78
1.74
Price-to-Graham-Number 1.64
SHTDF's Price-to-Graham-Number is ranked higher than
50% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.77 vs. SHTDF: 1.64 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SHTDF' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.53  Med: 1.79 Max: 3.28
Current: 1.64
1.53
3.28
Earnings Yield (Greenblatt) % 10.85
SHTDF's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.75 vs. SHTDF: 10.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SHTDF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.1  Med: 8.9 Max: 12
Current: 10.85
4.1
12
Forward Rate of Return (Yacktman) % 21.76
SHTDF's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.60 vs. SHTDF: 21.76 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SHTDF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 21.76  Med: 31.5 Max: 45.7
Current: 21.76
21.76
45.7

More Statistics

Revenue (TTM) (Mil) $38,253
EPS (TTM) $ 0.25
Beta0.74
Short Percentage of Float0.00%
52-Week Range $4.08 - 5.15
Shares Outstanding (Mil)2,767.10

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)